Why TransMedics Stock Is Skyrocketing Today
Shares of next-generation transplant technology platform TransMedics (NASDAQ: TMDX) were up 21% as of noon ET on Friday, according to data provided by S&P Global Market Intelligence.TransMedics reported first-quarter results that saw revenue balloon 48% and the company's net income margin rise from 13% a year ago to 18% today. On top of these results blowing away analysts' expectations, management raised its 2025 sales guidance from 23% at the midpoint to 30%, sparking an optimistic reaction from the market.Continue reading
Shares of next-generation transplant technology platform TransMedics (NASDAQ: TMDX) were up 21% as of noon ET on Friday, according to data provided by S&P Global Market Intelligence.
TransMedics reported first-quarter results that saw revenue balloon 48% and the company's net income margin rise from 13% a year ago to 18% today.
On top of these results blowing away analysts' expectations, management raised its 2025 sales guidance from 23% at the midpoint to 30%, sparking an optimistic reaction from the market.
